Microbot Medical (MBOT) Return on Capital Employed (2011 - 2026)
Microbot Medical's (MBOT) quarterly Return on Capital Employed came in at 20.99% in Q1 2026, up 5302.0% YoY from 0.39% in Q1 2025, and down 11.39% on a QoQ basis from 18.85% in Q4 2025.
Microbot Medical (MBOT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Microbot Medical (MBOT) has 16 years of Return on Capital Employed data on file, last reported at 20.99% in Q1 2026.
- Quarterly Return on Capital Employed rose 5302.0% year-over-year to 20.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.99% (up 5302.0% YoY) and the FY2025 annual result came in at 36.52%, up 20982.0% from the prior year.
- Return on Capital Employed retreated to 20.99% in Q1 2026, from 18.85% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 18.85% in Q4 2025 to a low of 367.94% in Q4 2024.
- A 5-year average of 136.34% and a median of 139.86% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 21387 bps — and 2025, when it soared 34909 bps.
- Tracing MBOT's Return on Capital Employed over 5 years: stood at 207.39% in 2022, then advanced by 26 bps to 154.07% in 2023, then slumped by 139 bps to 367.94% in 2024, then jumped by 95 bps to 18.85% in 2025, then fell by 11 bps to 20.99% in 2026.
- The last three Return on Capital Employed figures came in at 20.99% (Q1 2026), 18.85% (Q4 2025), and 25.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Microbot Medical | 101.07 Mn | 101.07 Mn | 2,000.00 | -20.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.99% |
| Dec 31, 2025 | -18.85% |
| Sep 30, 2025 | -25.75% |
| Jun 30, 2025 | -46.01% |
| Mar 31, 2025 | -74.01% |
| Dec 31, 2024 | -367.94% |
| Sep 30, 2024 | -207.33% |
| Jun 30, 2024 | -156.89% |
| Mar 31, 2024 | -139.86% |
| Dec 31, 2023 | -154.07% |
| Sep 30, 2023 | -129.30% |
| Jun 30, 2023 | -163.18% |
| Mar 31, 2023 | -196.16% |
| Dec 31, 2022 | -207.39% |
| Sep 30, 2022 | -193.16% |
| Jun 30, 2022 | -127.34% |
| Mar 31, 2022 | -89.60% |
| Dec 31, 2021 | -69.89% |
| Sep 30, 2021 | -51.82% |
| Jun 30, 2021 | -45.43% |